| 名稱 | CCDC6-RET V804M/BaF3激酶細(xì)胞 |
| 型號(hào) | CBP73216 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | CCDC6-RET V804M/BaF3激酶細(xì)胞 |
產(chǎn)品搜索
相關(guān)文章
- 證據(jù)：鍛煉或許并不是控制體重的關(guān)鍵
- CD74-ROS1的藥靶模型+DNARNA標(biāo)準(zhǔn)品+ddPCR試劑盒
- 心衰治療靶點(diǎn)：BNP/NPR1
- 腫瘤細(xì)胞能無(wú)限分裂的原因有哪些？
- 黃金賽道——CDH17靶點(diǎn)
- 腫瘤細(xì)胞內(nèi)的膠原蛋白有哪些作用？
- 【新品上線】一種安全高效的中和抗體體外篩選模型
- VKORC1基因多態(tài)性用藥指導(dǎo)標(biāo)準(zhǔn)品
- 上海細(xì)胞中心人員需了解的專業(yè)“術(shù)語(yǔ)”
- 細(xì)胞株購(gòu)買(mǎi)為何比較看重生物等級(jí)？
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73216CCDC6-RET V804M/BaF3激酶細(xì)胞
- 詳細(xì)內(nèi)容
CCDC6-RET V804M/BaF3激酶細(xì)胞
| CBP73216 | |
| I. Introduction | |
Cell Line Name： | CCDC6-RET [V804M]/BaF3 |
Host Cell: | BA/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+2ug/ml puromycin |
Mycoplasma Status: | Negative |
| II.Background | |
CCDC6, coiled-coil domain containing 6, has been shown to play a role in the DNA damaging signaling pathway acting as a substrate of ATM (PMID: 17420723). CCDC6 fusions with RET (PMID: 23154560, PMID: 26078337) and BRAF (PMID: 26314551) have been observed in multiple cancer types. | |
| III. Representative Data | |
1. CCDC6-RET V804M/BaF3
| |
2. Sanger of CCDC6-RET [V804M]/BaF3 | |
Figure 2. Breakpoint of CCDC6-RET V804M/BaF3 | |
Figure 3. Point mutation of CCDC6-RET V804M/BaF3 | |
| 3.Anti-proliferation assay | |
Figure 4. CTG Assay for CCDC6-Ret V804M BaF3 Proliferation. | |
會(huì)員_a.png)